Free from Publisher

Somatostatin receptor imaging and theranostics: current practice and future prospects

S Park, AS Parihar, L Bodei, TA Hope… - Journal of Nuclear …, 2021 - Soc Nuclear Med
A new era of precision diagnostics and therapy for patients with neuroendocrine neoplasms
began with the approval of somatostatin receptor (SSTR) radiopharmaceuticals for PET …
被引用次数：39 相关文章

Somatostatin receptor imaging and theranostics: Current practice and future prospects

S Park, AS Parihar, L Bodei, TA Hope… - Journal of Nuclear …, 2021 - ohsu.elsevierpure.com
A new era of precision diagnostics and therapy for patients with neuroendocrine neoplasms
began with the approval of somatostatin receptor (SSTR) radiopharmaceuticals for PET …

Somatostatin Receptor Imaging and Theranostics: Current Practice and Future Prospects

S Park, AS Parihar, L Bodei, TA Hope… - CALL FOR …, 2021 - Soc Nuclear Med
A new era of precision diagnostics and therapy for patients with neuroendocrine neoplasms
began with the approval of somatostatin receptor (SSTR) radiopharmaceuticals for PET …
[PDF] archive.org

[PDF][PDF] Somatostatin Receptor Imaging and Theranostics: Current Practice and Future Prospects

S Park, AS Parihar, L Bodei, TA Hope… - THE JOURNAL OF …, 2021 - scholar.archive.org
A new era of precision diagnostics and therapy for patients with neuroendocrine neoplasms
began with the approval of somatostatin receptor (SSTR) radiopharmaceuticals for PET …

Somatostatin Receptor Imaging and Theranostics: Current Practice and Future Prospects.

S Park, AS Parihar, L Bodei, TA Hope… - Journal of Nuclear …, 2021 - europepmc.org
A new era of precision diagnostics and therapy for patients with neuroendocrine neoplasms
began with the approval of somatostatin receptor (SSTR) radiopharmaceuticals for PET …

Somatostatin receptor imaging and theranostics: Current practice and future prospects

S Park, AS Parihar, L Bodei, TA Hope… - Journal of Nuclear …, 2021 - profiles.wustl.edu
A new era of precision diagnostics and therapy for patients with neuroendocrine neoplasms
began with the approval of somatostatin receptor (SSTR) radiopharmaceuticals for PET …
[HTML] nih.gov

[HTML][HTML] Somatostatin Receptor Imaging and Theranostics: Current Practice and Future Prospects

S Park, AS Parihar, L Bodei, TA Hope… - Journal of Nuclear …, 2021 - ncbi.nlm.nih.gov
A new era of precision diagnostics and therapy for patients with neuroendocrine neoplasms
began with the approval of somatostatin receptor (SSTR) radiopharmaceuticals for PET …

Somatostatin Receptor Imaging and Theranostics: Current Practice and Future Prospects.

S Park, A Parihar, L Bodei, N Mallak… - Journal of Nuclear …, 2021 - escholarship.org
A new era of precision diagnostics and therapy for patients with neuroendocrine neoplasms
began with the approval of somatostatin receptor (SSTR) radiopharmaceuticals for PET …

Somatostatin Receptor Imaging and Theranostics: Current Practice and Future Prospects

S Park, AS Parihar, L Bodei… - Journal of nuclear …, 2021 - pubmed.ncbi.nlm.nih.gov
A new era of precision diagnostics and therapy for patients with neuroendocrine neoplasms
began with the approval of somatostatin receptor (SSTR) radiopharmaceuticals for PET …

[引用][C] Somatostatin Receptor Imaging and Theranostics: Current Practice and Future Prospects

S Park, AS Parihar, L Bodei, TA Hope… - Journal of Nuclear …, 2021 - cir.nii.ac.jp
Somatostatin Receptor Imaging and Theranostics: Current Practice and Future Prospects |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …